Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categories:

247 Episoade

  1. A Method for Tapering Antipsychotics

    Publicat: 08.12.2021
  2. Management of Psychiatric Comorbidities With Alcohol Use Disorder

    Publicat: 03.12.2021
  3. Tips for Treating Perimenopausal Depression

    Publicat: 28.11.2021
  4. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

    Publicat: 23.11.2021
  5. Subclinical Hypothyroidism in Depressed Adolescents

    Publicat: 18.11.2021
  6. Principles for Managing Alcohol Use Disorder

    Publicat: 13.11.2021
  7. ECT for Depressed Patients With Borderline Personality Disorder

    Publicat: 08.11.2021
  8. Assessing and Treating Alcohol Withdrawal

    Publicat: 03.11.2021
  9. Lab Tests in Psychopharmacology

    Publicat: 29.10.2021
  10. Technology-Facilitated Adherence Enhancement and Family Involvement

    Publicat: 24.10.2021
  11. Drug-Induced Hyperthermic Syndromes in Psychiatry

    Publicat: 19.10.2021
  12. How to Improve Adherence: Targeting Reasons for Nonadherence

    Publicat: 14.10.2021
  13. Esketamine: Postmarketing Safety Concerns

    Publicat: 09.10.2021
  14. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Publicat: 04.10.2021
  15. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicat: 29.09.2021
  16. How to Assess Psychotropic Drug Adherence

    Publicat: 24.09.2021
  17. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicat: 19.09.2021
  18. Delirium, Catatonia, and COVID-19

    Publicat: 14.09.2021
  19. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicat: 09.09.2021
  20. Dopamine and Depression: Clinical Considerations

    Publicat: 04.09.2021

12 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site